A significant correlation was found between increased SLC41A3 expression and increased MSI in various cancers, such as CESC, LIHC, and TGCT, while, decreased SLC41A3 expression was inversely correlated with MSI in DLBC and LAML (Figure 8B). The gene discussed is SLC41A3; the disease is cancer.